Fatima Yucel

Identification ofPseudomonas viridiflava on tomato by traditional methods and enzyme-linked immunosorbent assay

Pseudomonas viridiflava is one of the causal agents of tomato stem necrosis in the eastern Mediterranean region of Turkey. The bacterium causes general wilting, yellowing of tomato plants, dark blotches on the pruning sites of the stem, browning, and hollowing of the pith.P. viridiflava strains, isolated from Antakya and Mersin, were identified by traditional methods and indirect enzyme-linked immunosorbent assay (ELISA). For indirect-ELISA, polyclonal antisera were produced against a regional isolate ofP. viridiflava (AD-OZ 3a). Using indirect-ELISA, the pathogenic bacterium was identified rapidly and safely from both pure culture and inoculated plants in 2 days. There was no cross reaction with other stem necrosis pathogens. With indirect-ELISA, the lower limit forP. viridiflava detection in pure culture was 103 colony-forming units per milliliter.

Generation of Anti-Idiotypic Antibodies that Mimic HBsAg and Vaccination against Hepatitis B Virus

The advent of hybridoma technology has opened up a new avenue in vaccine development, and antigen-mimicking properties of anti-idiotypic antibodies have provided promising alternatives in the generation of experimental anti-idiotypic vaccines. In the present study, mice were immunized with anti-hepatitis B virus (HBV) mouse monoclonal and anti-HBV goat polyclonal antibody to produce anti-idiotypic antibodies. Two mouse monoclonal antibodies (6C9, 6H9) were obtained from the fusions, and the immunogenic properties and specificity of antibodies were analyzed. BALB/c mice were immunized with varying concentrations of anti-idiotypic antibodies (25, 50, 75, and 100 micrograms of anti-Id), and it was shown that anti-idiotypic antibodies generated hepatitis B surface antigen (HBsAg), as well as a BSA-specific antibody response. A simple method for the purification of monoclonal antibodies by dialyzing antibody against water has also been reported.

Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow

Since its discovery by Kohler and Milstein in 1975, hybridoma technology has found a wide use in almost every field of biology and medicine. A general and simple approach for developing monoclonal antibodies is to use splenocytes from immunized mice. In the present study, 10 fusion experiments were carried out to analyze the hybridization efficiencies of mouse myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow and we found a higher yield of antigen specific antibody producing hybridoma lines when the lymph nodes were used.

Diagnostic kit studies for the determination of IGM antibody to hepatitis b virus core antigen (HBcAg)

Zuckerman AJ., 1996. Hepatitis Viruses. In: Barrons Medical Microbiology . Wang A-X, Coulepis AG, Hui Z, et al. Immunoglobulin M antibodies against hepatitis B core antigen in patients with chronic hepatitis B infection. Pathol 1984;16:83-5. John R. Crowther,The ELISA Guidebook NEW by John R. Crowther; Methods in Molecular Biology ,vol 149,2000.. -Engvall E, Perlmann P. Enzyme-linked Immunosorbent Assay, ELISA(in) Protides of the Biological Fluids. Proceedings of the Nineteenth Colloquium, Brugge (Peeters H, ed.), Pergamon Press, Oxford, pp.553-556, 1971. T. Porstmann ,S.T. Kiessig; Enzyme immunoassay techniques ;An overviewJournal of lmmunological Methods, 150 (1992) 5--21 Hoofnagle JH, Gerety RJ, Barker LF. Antibody to hepatitis-B-virus core in man. Lancet 1973; 2:869-873. -Nakane P.K., and Kawaoi A.: Peroxidase-labelled antibody, a new method of conjugation, J. Histochem, 1974; 22; 1084